Chardan’s experience in healthcare SPACs runs deep. We pioneered the first biotech SPAC, opening the door to what is now an exploding space. With in-depth coverage across the life sciences sector, Chardan has both the buy-side relationships and deal pipeline to help you be successful. We lead with precise execution and a scientific approach that allows us to see opportunities missed by Wall Street.

Success story – Health Sciences merger with Immunovant (IMVT)

• As of November 2020, one of the top performing SPAC transactions of all time
• Advised on strategy and structure
• Coordinated roadshow
• Secured $150MM investment
• Advised on $61MM warrant tender
• Additional $35MM bridge for R&D
• Participated in two post-merger follow-on transactions raising an additional $321MM

Learn more about IMVT

We’ve been deeply involved in fintech for 20 years. Members of our team have founded, managed and successfully exited fintech companies. Our combined SPAC product and domain expertise gives us experience on all sides of the transaction – as entrepreneurs, sponsors and investors. Through strong leadership and execution, we bring compelling fintech SPAC opportunities to the market.

Success story – 8i Enterprises merger with Diginex

• Advised on listing, structure and regulatory elements
• Diginex raised more than $20 million in a convertible note, upsized from an initial target of $15 million
• Crafted and supported key communication between investors and 8i Enterprises and Diginex throughout the SPAC M&A process
• The merger was announced in July 2019 and closed in September 2020 with a transaction value of $317M

Learn more about Diginex

Chardan’s first sponsored SPAC in 2005 was focused in Asia and resulted in a successful business combination with a Chinese company. Since then, we’ve raised capital for 54 international SPACs IPOs, over $4.1 billion in transaction value and 27 international SPAC business combinations, over $10 billion in transaction value. With world-class leadership, an expansive network of global business and investor relationships, and a boots on the ground approach, we are successfully building a presence in the world’s most dynamic markets.

Success story – EdTechX Holdings merger with Meten (METX)

• First SPAC in education services, merged with leading China-based education service company
• Chardan served as lead coordinator for international roadshow
• Completed $36 million private placement with global investor base
• Closed successful transaction despite global pandemic/market turmoil in March 2020

Learn more about EdTechX

Our experience with disruptive businesses doesn't end with healthcare and fintech. Chardan has carved out a leadership position across a broad range of sectors, having underwritten 45 diverse-sector SPAC IPOs, raising over $15 billion in transaction value. From inception through the de-SPAC, Chardan is there every step of the way. 

• TMT
• Industrial
• Energy & Resources
• Consumer
• Education
• And more

Success story – VectoIQ IPO (NKLA)

• SPAC focused on automotive technology
• Joint bookrunner on $230MM IPO
• Acquired electric engine designer and manufacturer Nikola Motor Company (NKLA)
• $700MM raised to fund future growth
• Combined entity one of the most high profile SPACs

Learn more about VectoIQ